Overview

Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in Normal Eyes

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the effect of brimonidine tartrate ophthalmic solution 0.15% (Alphagan P) on pupil diameter under different luminance conditions.
Details
Lead Sponsor:
Walter Reed Army Medical Center
Treatments:
Brimonidine Tartrate
Ophthalmic Solutions
Pharmaceutical Solutions